An update on the role of miR-379 in human disorders

Biomedicine & Pharmacotherapy - Tập 139 - Trang 111553 - 2021
Soudeh Ghafouri-Fard1, Donya Shaterabadi2, Afete Abak3, Hamed Shoorei4, Zahra Bahroudi5, Mohammad Taheri6, Seyed Ali Mousavinejad7
1Department of medical genetics, Shahid Beheshti university of medical sciences, Tehran, Iran
2Department of Medical Nanotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences, Tabriz, Iran
3Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
4Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
5Department of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
6Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Tài liệu tham khảo

Glazov, 2008, Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals, Mol. Biol. Evol., 25, 939, 10.1093/molbev/msn045

Seitz, 2004, A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain, Genome Res., 14, 1741, 10.1101/gr.2743304

Fiore, 2009, Mef2–mediated transcription of the miR379–410 cluster regulates activity‐dependent dendritogenesis by fine‐tuning Pumilio2 protein levels, EMBO J., 28, 697, 10.1038/emboj.2009.10

Guia, 2015, microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis, EMBO J., 34, 344, 10.15252/embj.201490464

Sanson, 2020, miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy, Sci. Rep., 10, 1, 10.1038/s41598-020-66016-7

Marty, 2016, Deletion of the miR-379/miR-410 gene cluster at the imprinted Dlk1-Dio3 locus enhances anxiety-related behaviour, Hum. Mol. Genet., 25, 728, 10.1093/hmg/ddv510

Labialle, 2014, The miR‐379/miR‐410 cluster at the imprinted Dlk1–Dio3 domain controls neonatal metabolic adaptation, EMBO J., 33, 2216, 10.15252/embj.201387038

Nayak, 2018, Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma, Sci. Rep., 8, 1, 10.1038/s41598-018-26000-8

Kumar, 2018, Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas, J. Neuro Oncol., 139, 23, 10.1007/s11060-018-2840-6

Wei, 2019, MicroRNA‐379 inhibits laryngeal carcinoma cell proliferation and invasion through directly targeting TCF‐4, Kaohsiung J. Med. Sci., 35, 731, 10.1002/kjm2.12109

Zhang, 2020, MicroRNA-379-5p/YBX1 axis regulates cellular EMT to suppress migration and invasion of nasopharyngeal carcinoma cells, Cancer Manag. Res., 12, 4335, 10.2147/CMAR.S253504

Guo, 2020, Circ_0011292 enhances paclitaxel resistance in non-small cell lung cancer by regulating miR-379-5p/TRIM65 axis, Cancer Biother. Radiopharm., 10.1089/cbr.2019.3546

Jiang, 2020, miR‑379–5p inhibits cell proliferation and promotes cell apoptosis in non‑small cell lung cancer by targeting β‑arrestin‑1, Mol. Med. Rep., 22, 4499, 10.3892/mmr.2020.11553

Zhou, 2017, MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathways., Oncol. Rep., 38, 1857, 10.3892/or.2017.5835

Jun, 2020, Circ_SIPA1L1 promotes osteosarcoma progression via miR-379-5p/MAP3K9 Axis, Cancer Biother. Radiopharm., 10.1089/cbr.2020.3891

Xie, 2017, MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2, Biosci. Rep., 37, 10.1042/BSR20160542

Li, 2017, Micro RNA‐379 suppresses osteosarcoma progression by targeting PDK 1, J. Cell. Mol. Med., 21, 315, 10.1111/jcmm.12966

Ji, 2020, LINC00665 promotes breast cancer progression through regulation of the miR-379-5p/LIN28B axis, Cell Death Dis., 11, 1, 10.1038/s41419-019-2213-x

Khan, 2013, miR-379 regulates cyclin B1 expression and is decreased in breast cancer, PloS One, 8, 10.1371/journal.pone.0068753

O’brien, 2018, Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379, Oncogene, 37, 2137, 10.1038/s41388-017-0116-9

Chen, 2016, MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma, Cancer Lett., 375, 73, 10.1016/j.canlet.2016.02.043

Yamamoto, 2014, MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma, Oncol. Rep., 32, 2365, 10.3892/or.2014.3481

Xu, 2017, MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer, Int. J. Oncol., 51, 867, 10.3892/ijo.2017.4072

Gururajan, 2014, miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer, Clin. Cancer Res., 20, 6559, 10.1158/1078-0432.CCR-14-1784

Wu, 2017, MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2, Oncol. Rep., 37, 3502, 10.3892/or.2017.5607

Wang, 2020, MiR-379 inhibits proliferation and induces apoptosis in multiple myeloma by targeting Y-box binding protein 1, Trop. J. Pharm. Res., 19, 1843, 10.4314/tjpr.v19i9.7

Li, 2019, Regulation of gasdermin D by miR-379-5p is involved in arsenite-induced activation of hepatic stellate cells and in fibrosis via secretion of IL-1β from human hepatic cells, Metallomics, 11, 483, 10.1039/C8MT00321A

Dang, 2018, MicroRNA-379-5p is associated with biochemical premature ovarian insufficiency through PARP1 and XRCC6, Cell Death Dis., 9, 1, 10.1038/s41419-017-0163-8

Jee, 2018, Mir-374-5p, mir-379-5p, and mir-503-5p regulate proliferation and hypertrophic differentiation of growth plate chondrocytes in male rats, Endocrinology, 159, 1469, 10.1210/en.2017-00780

Guia, 2015, micro RNA‐379 couples glucocorticoid hormones to dysfunctional lipid homeostasis, EMBO J., 34, 344, 10.15252/embj.201490464

Werk, 2014, Genetic variants may play an important role in mRNA–miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379, Pharm. Genom., 24, 283, 10.1097/FPC.0000000000000046

Haenisch, 2011, Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379, Mol. Pharmacol., 80, 314, 10.1124/mol.110.070714

Li, 2017, miR-379 inhibits cell proliferation, invasion, and migration of vascular smooth muscle cells by targeting insulin-like factor-1, Yonsei Med. J., 58, 234, 10.3349/ymj.2017.58.1.234

Liu, 2020, MicroRNA‐379 mediates pigmentation, migration and proliferation of melanocytes by targeting the insulin‐like growth factor 1 receptor, Exp. Dermatol., 29, 467, 10.1111/exd.14095

Gao, 2015, Regulation of DLK1 by the maternally expressed miR-379/miR-544 cluster may underlie callipyge polar overdominance inheritance, Proc. Natl. Acad. Sci., 112, 13627, 10.1073/pnas.1511448112

Okamoto, 2020, Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease, PloS One, 15, 10.1371/journal.pone.0219412

Dasgupta, 2021, Recent advances in miRNA delivery systems, Methods Protoc., 4, 10, 10.3390/mps4010010